T1	Participants 48 86	third-party blood transfusion protocol
T2	Participants 117 149	Antigen pre-treatment in animals
T3	Participants 212 250	pre-transplantation blood transfusions
T4	Participants 457 508	planned programme of third-party blood transfusions
T5	Participants 588 724	24 patients were recruited to the study; ten received cyclosporin with blood transfusions (BT) (group 1), 14 received BT alone (group 2)
